Back to the list
Congress: ECR25
Poster Number: C-14348
Type: Poster: EPOS Radiologist (scientific)
Authorblock: L. Ye, K. Tao, Y. Xu, M-X. Yang, H. Luo, H-Y. Xu, Y-K. Guo; Chengdu/CN
Disclosures:
Lu Ye: Nothing to disclose
Kai Tao: Nothing to disclose
Yanjiani Xu: Nothing to disclose
Meng-Xi Yang: Nothing to disclose
Hong Luo: Nothing to disclose
Hua-Yan Xu: Nothing to disclose
Ying-Kun Guo: Nothing to disclose
Keywords: Cardiac, MR, Chemotherapy, Treatment effects, Cancer, Toxicity
References
  1. Alvarez-Cardona, J. A., Ray, J., Carver, J., Zaha, V., Cheng, R., Yang, E., et al.   Cardio-Oncology Education and Training: JACC Council Perspectives.J Am Coll Cardiol, 2020. 76(19): p. 2267-2281.
  2. Lenneman, C.G. and Sawyer,D.B., Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment. Circ Res, 2016. 118(6): p. 1008-20.
  3. Armstrong, D. K., Alvarez, R. D., Bakkum-Gamez, J. N., Barroilhet, L., Behbakht, K., Berchuck, A., et al. Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw, 2021. 19(2): p. 191-226.
  4. Yeh, E.T. and Bickford,C.L. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol, 2009. 53(24): p. 2231-47.
  5. Makavos, G., Ikonomidis, I., Palios, J., Rigopoulos, A., Katogiannis, K., Parissis, J., et al.  Cardiac imaging in cardiotoxicity: a focus on clinical practice.Heart Fail Rev, 2021. 26(5): p. 1175-1187.
  6. Pedrizzetti, G., Claus, P., Kilner, P. J. and Nagel, E. Principles of cardiovascular magnetic resonance feature tracking and echocardiographic speckle tracking for informed clinical use. J Cardiovasc Magn Reson, 2016. 18(1): p. 51.
  7. Xu, J., Yang, W., Zhao, S. and Lu, M. State-of-the-art myocardial strain by CMR feature tracking: clinical applications and future perspectives. Eur Radiol, 2022. 32(8): p. 5424-5435.
  8. Calvillo-Argüelles, O., Thampinathan, B., Somerset, E., Shalmon, T., Amir, E., Steve Fan, C. P., et al. Diagnostic and Prognostic Value of Myocardial Work Indices for Identification of Cancer Therapy-Related Cardiotoxicity.JACC Cardiovasc Imaging, 2022. 15(8): p. 1361-1376.
  9. Houbois, C. P., Nolan, M., Somerset, E., Shalmon, T., Esmaeilzadeh, M., Lamacie, M. M., et al. Serial Cardiovascular Magnetic Resonance Strain Measurements to Identify Cardiotoxicity in Breast Cancer: Comparison With Echocardiography.JACC Cardiovasc Imaging, 2021. 14(5): p. 962-974.
  10. Ong, G., Brezden-Masley, C., Dhir, V., Deva, D. P., Chan, K. K. W., Chow, C. M., et al. Myocardial strain imaging by cardiac magnetic resonance for detection of subclinical myocardial dysfunction in breast cancer patients receiving trastuzumab and chemotherapy.Int J Cardiol, 2018. 261: p. 228-233.
  11. Jordan, J. H., Sukpraphrute, B., Meléndez, G. C., Jolly, M. P., D'agostino, R. B., Jr. andHundley, W. G. Early Myocardial Strain Changes During Potentially Cardiotoxic Chemotherapy May Occur as a Result of Reductions in Left Ventricular End-Diastolic Volume: The Need to Interpret Left Ventricular Strain With Volumes. Circulation, 2017. 135(25): p. 2575-2577.
  12. Jolly, M. P., Jordan, J. H., Meléndez, G. C., Mcneal, G. R., D'agostino, R. B., Jr. and Hundley, W. G. Automated assessments of circumferential strain from cine CMR correlate with LVEF declines in cancer patients early after receipt of cardio-toxic chemotherapy. J Cardiovasc Magn Reson, 2017. 19(1): p. 59.
GALLERY